Bethlem Myopathy Clinical Trial
Official title:
The Effect of a Bike Ergometer Training Program in Patients With Bethlem Myopathy
Muscular dystrophy is a group of disorders that are characterized by progressive muscle
weakening and loss of muscle mass, caused by defects in muscle proteins. Muscular dystrophy
is almost always inherited disorders, and so far, no curative treatments exist.
Previous studies have shown that endurance training significantly improves fitness and
self-assessed muscle function in a variety of muscular dystrophies. In this study, we wish
to investigate whether patients with Bethlem myopathy (a specific form of muscular
dystrophy) also benefit from endurance training.
The study consists of two test days, a 10-week training period and five blood tests.
Patients will be required to train, three times per week, for 10 weeks, on a bike ergometer
with a specific training intensity, under pulse rate monitoring.
The training period will be flanked by two test days, where we will determine, and compare
the patients' muscle strength and fitness level, from before to after the training program.
The patients conditioning level will be determined from a 15 minute cycle ergometer test and
patients will undergo three functional tests to determine their functional muscle strength.
We will as a safety measure analyze blood tests before, during and after the training
program for the muscle enzyme creatine kinase (an indicator of muscle damage) and through
adverse effects as reported by patients during weekly telephone-consultations with the
Principal investigator.
We anticipate, that Bethlem myopathy patients will have a similar rise in fitness level and
functional muscle strength, as that seen in patients with other forms of muscular dystrophy,
who undertake a similar training program.
Status | Completed |
Enrollment | 7 |
Est. completion date | January 2015 |
Est. primary completion date | December 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 16 Years to 90 Years |
Eligibility |
Inclusion Criteria: - Patients with Bethlem myopathy Exclusion Criteria: - Patients with disorders that would confound the interpretation of the effect from training (cardiomyopathy, pregnant women, etc.) - Patients who are deemed mentally unfit for cooperation with the training program |
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Denmark | Rigshospitalet, Neuromuscular Research Unit, section 3342 | Copenhagen |
Lead Sponsor | Collaborator |
---|---|
Rigshospitalet, Denmark |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Safety | The safety of undertaking a 10-week training program will be determined by analyzing reports of adverse effects faced during the training program, and by interpretation of Creatine Kinase levels measured before, during and after the training program. | During a 10 week training program | Yes |
Primary | Maximal oxygen uptake (VO2max) | VO2max will be determined during an incremental bike test to exhaustion. VO2max is a physiological measure of physical fitness. VO2max relies on a persons ability to supply and consume oxygen ("energy") in muscle tissue. | after 10 week bike ergometer training program | No |
Secondary | Functional muscle strength | Functional muscle strength will be determined by performance in three functional tests: a five-repetition-sit-to-stand-test, a 6 minute walk test and a 14 step stair test. | After completion of a 10 week training program | No |
Secondary | Muscle strength determined by dynamometry | After completion of a 10 week training program | No | |
Secondary | Self-assessed improvements in muscle function | After completion of a 10 week training program | No | |
Secondary | Self-assessed improvements in incidence of problems that are related to inactivity (in patients who are confined to a wheel-chair) | After a 10 week training program | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03693898 -
MR in Patients With Collagen VI Related Myopathies
|
N/A | |
Completed |
NCT01438788 -
Low Protein Diet in Patients With Collagen VI Related Myopathies
|
Phase 2 | |
Recruiting |
NCT04020159 -
Global Registry for COL6-related Dystrophies
|